Related Experiment Video
Updated: Jul 19, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Prostate cancer gene therapy-what have we learned and where are we going?
Abstract:
With recent advances in genetic engineering, tumor biology, and immunology, gene therapy has been recognized as a promising new treatment option for various cancers, including prostate cancer. Several clinical trials of prostate cancer gene therapy, using therapeutic genes which include suicide genes, immunomodulatory genes, tumor suppressor genes, and anti-oncogenes, are under way and preliminary reports have emerged. Although gene therapy for prostate cancer is still at an early stage and requires additional technological breakthroughs, new insights obtained from recent clinical trials indicate a promising potential for prostate cancer gene therapy. In this report, general concepts, current progress, and future prospects in prostate cancer gene therapy are summarized.
Insights
Gene therapy offers a promising new avenue for treating prostate cancer, with ongoing clinical trials exploring various therapeutic genes. Despite early-stage challenges, recent insights highlight its significant potential for future cancer treatment.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Gene therapy is emerging as a viable treatment for various cancers.
- Prostate cancer research is exploring novel therapeutic strategies.
- Advances in genetic engineering and tumor biology are driving innovation.
Purpose of the Study:
- To summarize the general concepts of gene therapy for prostate cancer.
- To review the current progress of prostate cancer gene therapy clinical trials.
- To discuss the future prospects and potential of gene therapy in prostate cancer treatment.
Main Methods:
- Review of current clinical trials in prostate cancer gene therapy.
- Analysis of therapeutic genes used, including suicide, immunomodulatory, tumor suppressor, and anti-oncogenes.
- Synthesis of preliminary reports and emerging data.
Main Results:
- Several clinical trials for prostate cancer gene therapy are in progress.
- Preliminary data from trials using diverse therapeutic genes are emerging.
- Gene therapy shows promise despite being in the early stages of development.
Conclusions:
- Prostate cancer gene therapy is an evolving field with significant potential.
- Technological advancements are crucial for overcoming current limitations.
- Recent clinical trial insights indicate a promising future for gene therapy in oncology.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Gene Therapy
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics